These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 10841710

  • 1. Gene therapy on trial.
    Marshall E.
    Science; 2000 May 12; 288(5468):951-7. PubMed ID: 10841710
    [No Abstract] [Full Text] [Related]

  • 2. Tighter watch urged on adenoviral vectors...with proposal to report all 'adverse events'.
    Smaglik P.
    Nature; 1999 Dec 16; 402(6763):707. PubMed ID: 10617181
    [No Abstract] [Full Text] [Related]

  • 3. Virus treatment questioned after gene therapy death.
    Lehrman S.
    Nature; 1999 Oct 07; 401(6753):517-8. PubMed ID: 10524611
    [No Abstract] [Full Text] [Related]

  • 4. NIH under fire over gene-therapy trials..
    Wadman M.
    Nature; 2000 Jan 20; 403(6767):237. PubMed ID: 10659820
    [No Abstract] [Full Text] [Related]

  • 5. Gene therapy investigations proliferate.
    Hollon T.
    Nat Med; 2000 Mar 20; 6(3):235. PubMed ID: 10700200
    [No Abstract] [Full Text] [Related]

  • 6. NIH tightens up monitoring of gene-therapy mishaps.
    Smaglik P.
    Nature; 2000 Mar 02; 404(6773):5. PubMed ID: 10716412
    [No Abstract] [Full Text] [Related]

  • 7. Green light for gene therapy in healthy volunteers.
    Fox JL.
    Nat Biotechnol; 1997 Apr 02; 15(4):314. PubMed ID: 9094121
    [No Abstract] [Full Text] [Related]

  • 8. Review panel cancels meeting as gene therapy proposals fall.
    Wadman M.
    Nature; 1996 Feb 22; 379(6567):668. PubMed ID: 11644770
    [No Abstract] [Full Text] [Related]

  • 9. Federal agency keeps review committee after public comments support continuation.
    Maloney DM.
    Hum Res Rep; 1997 Jan 22; 12(1):1-2. PubMed ID: 11654603
    [No Abstract] [Full Text] [Related]

  • 10. Making clinical trials safer for human subjects.
    Baram M.
    Am J Law Med; 2001 Jan 22; 27(2-3):253-82. PubMed ID: 11467112
    [No Abstract] [Full Text] [Related]

  • 11. Special informed consent requirements are included in protocol review procedures.
    Maloney DM.
    Hum Res Rep; 1995 Jul 22; 10(7):1-2. PubMed ID: 11654274
    [No Abstract] [Full Text] [Related]

  • 12. Beyond localism: a proposal for a National Research Review Board.
    Levine C, Caplan AL.
    IRB; 1986 Jul 22; 8(2):7-9. PubMed ID: 11649751
    [No Abstract] [Full Text] [Related]

  • 13. More flexibility on reporting to federal agencies about injuries to research subjects.
    Maloney DM.
    Hum Res Rep; 2002 Jan 22; 17(1):1-2. PubMed ID: 16270435
    [No Abstract] [Full Text] [Related]

  • 14. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C.
    IRB; 1998 Jan 22; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract] [Full Text] [Related]

  • 15. Panel approves gene trial for "normals".
    Marshall E.
    Science; 1997 Mar 14; 275(5306):1561. PubMed ID: 9072819
    [No Abstract] [Full Text] [Related]

  • 16. A tumultuous year for gene therapy.
    Verma IM.
    Mol Ther; 2000 Nov 14; 2(5):415-6. PubMed ID: 11082313
    [No Abstract] [Full Text] [Related]

  • 17. Gene therapy approval may be rocky road for industry.
    Gavaghan H.
    Nature; 1995 Mar 16; 374(6519):202. PubMed ID: 7885431
    [No Abstract] [Full Text] [Related]

  • 18. Gene therapy panel gets a thumbs up.
    Science; 1995 Nov 24; 270(5240):1287. PubMed ID: 11644754
    [No Abstract] [Full Text] [Related]

  • 19. Development of a points to consider document for human somatic cell gene therapy.
    Milewski EA.
    Recomb DNA Tech Bull; 1985 Dec 24; 8(4):176-80. PubMed ID: 3867980
    [No Abstract] [Full Text] [Related]

  • 20. Vector-related tumorigenesis not found in ornithine transcarbamylase-deficient mice.
    Koeberl DD.
    Mol Ther; 2006 Jul 24; 14(1):1-2. PubMed ID: 16750655
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.